Identification of senescence-related molecular subtypes and key genes for prostate cancer

Identification of senescence-related molecular subtypes and key genes for prostate cancer

We identified distinct senescence-related molecular subtypes and critical genes among prostate cancer (PCa) patients undergoing radical prostatectomy (RP) or radical radiotherapy (RT). We conducted all analyses using R software and its suitable packages. Twelve genes, namely, secreted frizzled-relat...

Full description

Bibliographic Details
Main Authors:	De-Chao Feng, Wei-Zhen Zhu, Xu Shi, Qiao Xiong, Jia You, Qiang Wei, Lu Yang
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Asian Journal of Andrology
Subjects:	cellular senescence; immune checkpoints; molecular subtypes; prostate cancer; tumor immune environment
Online Access:	http://www.ajandrology.com/article.asp?issn=1008-682X;year=2023;volume=25;issue=2;spage=223;epage=229;aulast=Feng

Similar Items

Identification of cell senescence molecular subtypes in prediction of the prognosis and immunotherapy of hepatitis B virus-related hepatocellular carcinoma
by: Xue Yu, et al.
Published: (2022-10-01)

Senescence-associated lncRNAs indicate distinct molecular subtypes associated with prognosis and androgen response in patients with prostate cancer
by: Dechao Feng, et al.
Published: (2023-08-01)

A gene prognostic index from cellular senescence predicting metastasis and radioresistance for prostate cancer
by: Dechao Feng, et al.
Published: (2022-06-01)

Senescence-associated secretory phenotype constructed detrimental and beneficial subtypes and prognostic index for prostate cancer patients undergoing radical prostatectomy
by: Dechao Feng, et al.
Published: (2023-08-01)

Characterization of Immune-Based Molecular Subtypes and Prognostic Model in Prostate Adenocarcinoma
by: Li Guo, et al.
Published: (2022-06-01)

Identification of three immune molecular subtypes associated with immune profiles, immune checkpoints, and clinical outcome in multiple myeloma
by: Guangtao Gao, et al.
Published: (2021-10-01)

Predictive investigation of idiopathic pulmonary fibrosis subtypes based on cellular senescence-related genes for disease treatment and management
by: Changqing Yang, et al.
Published: (2023-03-01)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
by: Yang Song, et al.
Published: (2020-07-01)

Identification of Immune Subtypes of Esophageal Adenocarcinoma to Predict Prognosis and Immunotherapy Response
by: Chen Ling, et al.
Published: (2022-05-01)

Cellular senescence: A potential mode of circular RNAs regulating prostate cancer
by: Yunpeng Li, et al.
Published: (2023-12-01)

Comprehensive Analysis of Subtype-Specific Molecular Characteristics of Colon Cancer: Specific Genes, Driver Genes, Signaling Pathways, and Immunotherapy Responses
by: Fangjie Hu, et al.
Published: (2021-11-01)

Comprehensive Analysis of Senescence Characteristics Defines a Novel Prognostic Signature to Guide Personalized Treatment for Clear Cell Renal Cell Carcinoma
by: Peng Zhou, et al.
Published: (2022-06-01)

Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma
by: Bangrong Cao, et al.
Published: (2018-02-01)

Identifying cellular senescence associated genes involved in the progression of end-stage renal disease as new biomarkers
by: Yu-jia Xi, et al.
Published: (2023-08-01)

Immune microenvironment infiltration landscape and immune-related subtypes in prostate cancer
by: Wei Wu, et al.
Published: (2023-01-01)

Senescence and Aging: Does It Impact Cancer Immunotherapies?
by: Damien Maggiorani, et al.
Published: (2021-06-01)

A cellular senescence-related genes model allows for prognosis and treatment stratification of hepatocellular carcinoma: A bioinformatics analysis and experimental verification
by: Jiaming Li, et al.
Published: (2023-01-01)

A ubiquitin-related gene signature for predicting prognosis and constructing molecular subtypes in osteosarcoma
by: Nan Wei, et al.
Published: (2022-08-01)

Molecular Subtypes, microRNAs and Immunotherapy Response in Metastatic Colorectal Cancer
by: Alexandra Gherman, et al.
Published: (2024-02-01)

Exosomes orchestrates distinct molecular subtypes and key genes for the prostate cancer
by: Dechao Feng, et al.
Published: (2023-02-01)

An autophagy-related gene prognostic index predicting biochemical recurrence, metastasis, and drug resistance for prostate cancer
by: Wei-Zhen Zhu, et al.
Published: (2023-01-01)

Identification of a novel senescence-associated signature to predict biochemical recurrence and immune microenvironment for prostate cancer
by: Chenglin Han, et al.
Published: (2023-02-01)

Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer
by: Zhen Kang, et al.
Published: (2023-06-01)

DNA Damage- But Not Enzalutamide-Induced Senescence in Prostate Cancer Promotes Senolytic Bcl-xL Inhibitor Sensitivity
by: Nicolas Malaquin, et al.
Published: (2020-07-01)

Energy Metabolism-Related Gene Prognostic Index Predicts Biochemical Recurrence for Patients With Prostate Cancer Undergoing Radical Prostatectomy
by: Dechao Feng, et al.
Published: (2022-02-01)

Cellular senescence and the tumour microenvironment
by: Masaki Takasugi, et al.
Published: (2022-09-01)

A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance
by: Meng-Yao Xu, et al.
Published: (2024-04-01)

Immune-Related Gene-Based Novel Subtypes to Establish a Model Predicting the Risk of Prostate Cancer
by: Enchong Zhang, et al.
Published: (2020-11-01)

Identification of immune subtypes of melanoma based on single-cell and bulk RNA sequencing data
by: Linqian Guo, et al.
Published: (2023-01-01)

Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer
by: Changjing Wang, et al.
Published: (2022-06-01)

Immune Checkpoint Inhibitors in Prostate Cancer
by: Shobi Venkatachalam, et al.
Published: (2021-05-01)

Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes
by: Jing Chen, et al.
Published: (2022-08-01)

Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine
by: Xiaonan Zheng, et al.
Published: (2021-12-01)

The immune subtypes and landscape of sarcomas
by: Weiwei Weng, et al.
Published: (2022-09-01)

Cellular Plasticity: A Route to Senescence Exit and Tumorigenesis
by: Hadrien De Blander, et al.
Published: (2021-09-01)

Targeting Immune Senescence in Atherosclerosis
by: Danusha Michelle Vellasamy, et al.
Published: (2022-10-01)

Optimal combination of immune checkpoint and senescence molecule predicts adverse outcomes in patients with acute myeloid leukemia
by: Peipei Wang, et al.
Published: (2023-12-01)

Cellular senescence is a key mediator of lung aging and susceptibility to infection
by: Blake L. Torrance, et al.
Published: (2022-08-01)

Chemotherapy regimens induce inhibitory immune checkpoint protein expression on stem-like and senescent-like oesophageal adenocarcinoma cells
by: Maria Davern, et al.
Published: (2021-06-01)

The Identification of Senescence-Specific Genes during the Induction of Senescence in Prostate Cancer Cells
by: Steven R. Schwarze, et al.
Published: (2005-09-01)